Background
Introduction
Medications are the single most important factor in slowing, arresting, and occasionally reversing chronic heart failure (HF). Yet, medication adherence is poor in adults with HF. These patients take, on average, 10 different medications daily, most with multiple doses required.
Even among those with drug coverage insurance benefits, 40-60% adhere poorly to the prescribed regimen. 1 Over time, full adherence to the regimen may be as low as 10%. 2 Medication adherence is defined as the extent to which medications are taken as prescribed. 3 Both intentional and unintentional factors contribute to nonadherence. Intentional nonadherence is deliberate discontinuing, skipping or reducing the dose of medication. 4, 5 Factors known to contribute to such decisions include poor motivation, adverse side effects, perceived lack of effect, regimen complexity, being asymptomatic, individual perceptions (e.g., think the medicine is unnecessary) and poor health literacy. 6, 7 Unintentional nonadherence is careless missing of doses or errors due to factors such as forgetfulness and poor understanding of the prescribed instructions that is largely driven by a lack of capacity or resources to take medications. 6 The reasons underlying intentional and unintentional nonadherence may not be entirely independent in that certain types of unintentional nonadherence (e.g. forgetting) are logically more likely when patients are not motivated to take a medicine. 6 Medication nonadherence is known to be common in HF 8 and nonadherence is strongly associated with HF outcomes. 9 , 10 However, we know surprisingly little about the reasons for nonadherence in HF patients. In other populations, reasons for nonadherence are known to vary for different medications and different illnesses, [11] [12] [13] which highlights the importance of investigating nonadherence in subgroups of patients. Unintentional nonadherence is thought to be more common than intentional nonadherence, 14 but these dimensions of nonadherence have not been described in HF patients. Understanding the prevalence of and reasons for intentional and unintentional nonadherence can potentially contribute in important ways to the design of effective behavioral interventions to improve medication adherence. 15, 16 Thus, the objective of this study was to explore factors contributing to intentional and unintentional medication nonadherence in a sample of adults with chronic HF.
Theoretical Framework
The Common Sense Model (CSM) of Illness Representation was developed as a way of conceptualizing poor patient adherence with health-promoting behaviors. 17, 18 The CSM posits that illness perceptions (the illness label or diagnosis and associated symptoms), causes, timeline (acute, chronic or cyclical), consequences (social, monetary and health-related consequences of the illness and treatment) and control beliefs (the degree of control the patient thinks s/he has, the doctor has and the treatment has) affect behavior. 17, 19 Building on the CSM, Horne 5 developed the Necessity-Concerns-Framework ( Figure) , which specifies that medication adherence is a function an individual's illness beliefs. Illness beliefs lead to concerns and questions about whether a drug is really necessary, which may cause intentional nonadherence. A significant proportion of individuals are concerned that medicines are harmful, unnatural, and better avoided. 20 Horne notes that "unintentional nonadherence may be understood in terms of skills and abilities, whereas to understand intentional nonadherence we must consider patients' motivation to initiate and persist with the treatment regimen" 5 (p.67S). These elements of the Necessity-Concerns-Framework were used to explore intentional and unintentional factors contributing to medication nonadherence in adults with chronic HF.
Methods
This was a secondary analysis of qualitative data from four studies in the investigators' programs of HF self-care research. Secondary data analysis of qualitative data is a research strategy that makes use of existing qualitative data for the purposes of investigating new questions 21 or applying a new perspective or conceptual focus to the existing research. 22 There are numerous advantages to secondary data analysis of qualitative datasets 21 including the ability to generate new knowledge or new hypotheses, or support existing theories while reducing human subject burden. Secondary data analysis of qualitative data also allows wider use of data from typically underrepresented research subjects. 23 A key premise of secondary data analysis is that there is a fit between the primary data sets and the new research question that includes similar data collection and analytic techniques. 23, 24 In selecting datasets to include in a secondary data analysis, assessment of dataset quality, including depth or richness of data, is important to achieve answers to the proposed research question. 22 In this secondary analysis, qualitative data from four completed studies were analyzed, all of which explored biobehavioral and sociocultural influences on self-care or tested an intervention to improve self-care. A sample of 125 individuals participated in one of the four prior studies; medication adherence was discussed by 112 of these participants ( Table 1 ). The qualitative component of each prior study had been led by one of these authors (VVD), an experienced, highly trained qualitative methodologist. This investigator either personally interviewed participants or personally trained interviewers to collect the qualitative data. Each study complied with the Declaration of Helsinki, locally appointed ethics committees approved the research protocols, and informed consent was obtained from all participants.
Each study used a series of similar open-ended questions ("Tell me about your heart failure" and "What do you do on a daily basis to take care of your heart failure?") to elicit in-depth accounts of self-care. To gain insight into medication adherence, an essential component of HF self-care, focused questions about medication taking were asked ("Tell me about your medication").
Nonadherence was defined liberally in this qualitative analysis as skipping medication doses or reducing doses taken on an intermittent or frequent basis, regardless of cause. A liberal definition was used because no objective measure of medication taking behavior was available. Thus, medication adherence was judged based on patient statements. Barriers and facilitators to medication adherence were elicited through a series of follow-up probes asking about caregiver support for adherence and perceptions about importance of medication taking. Thus data collection and analytic techniques across studies were assured; and in-depth narratives about medication adherence provided for a rich qualitative dataset for this secondary analysis.
Qualitative Data Analysis
The qualitative data from these four studies were analyzed in a systematic manner using thematic content analysis. 25, 26 The steps of analysis are detailed in Table 2 . This process yielded a rich description and over 400 coded data segments about medication adherence. Individual findings were first reviewed first at the level of codes, focusing on the categories and themes originally coded as related to the medication adherence. Qualitative data were re-examined and re-coded by a single investigator (VVD) as reports of intentional and unintentional medication nonadherence.
Next, qualitative accounts of medication nonadherence were explored and organized within the theoretical context of the Necessity-Concerns-Framework. Finally, the pattern of themes was reviewed across studies. This within-study and across-study analysis was an iterative process involving a reanalysis of the original raw data and a reinterpretation of previous findings to answer additional questions about intentional and unintentional contributors to medication nonadherence.
Methodological rigor of the qualitative analysis was maintained through an audit trail, periodic debriefing with the co-investigator and discussions with colleagues knowledgeable about HF, medication adherence, and the Necessity-Concerns-Framework. Reliability was measured by consistency of interpretation and coding. 27 An audit trail of process and analytic memos and coding books was maintained to support the credibility of the study.
Results
Sample demographic and clinical characteristics are shown in Table 3 . The final sample consisted of 112 participants; 41 (37%) were women. Ages ranged from 25 to 98 years (mean age 59±15 years) with almost half (46%) older than 60 years. Most (58%) participants were
White and most had New York Heart Association (NYHA) class II (41%) or class III (55%) HF.
In this sample, 90% admitted to some amount of medication nonadherence. For many (60%), missing medication was unintentional and most commonly due to forgetfulness but 27% (n=30) admitted to intentionally skipping medication doses. Distinct patterns of behavior were evident.
Illness Perceptions and Perceived Need
Participants discussed experiencing typical HF symptoms including weight gain (43%), ankle swelling (50%), shortness of breath (54%), and fatigue (74%), but they did not always interpret these symptoms as related to HF. Symptom interpretation was based on prior experience and the severity of symptoms. Similarly, several described how the acute onset of symptoms like shortness of breath or chest pain signaled worsening HF and prompted medication taking to alleviate the symptom.
Fatigue and lack of energy, although mentioned by 74% of participants, were less often interpreted as HF-related. Many in this sample reported having a chronic, vague symptom like feeling tired, which they "have to get used to" rather than a symptom that can be managed with medication. Thus, the importance of medication to the management of these symptoms was rarely mentioned. In a very few cases (n=5), vague symptoms were recognized as representing HF and alleviated by medications; these patients knew that taking medication regularly was important. A 45 year old White male described the importance of his medication as, "My heart failure symptom is fatigue…probably the primary…I take my medication and I feel better…more energy…" These results suggest that symptom recognition and interpretation influence the perception of HF as a serious illness requiring medications.
Situational nonadherence was most frequently described by those who perceived HF as a low threat condition. In these cases, deliberate cognitive ("one day I forgot and there was no difference in how I felt…") and emotional ("…so if I am going to be out with my friends…I don't want to carry the pillbox…") processes were described as influencing actions. The pros and cons of taking medication were appraised, providing a rationale to the decision to purposively "skip medication". Certain situations like travel, vacation, work or family events outweighed the perceived need for medication.
Background Beliefs
When HF was perceived as inconsequential, negative attitudes regarding the importance of the medication regimen influenced adherence. Those who believed that the medication was either not helpful ("I was taking all these…10 pills … for years. In my opinion, they were not doing anything…so I stopped taking them…") or in conflict with their personal preferences ("I have always hated taking pills…so I skip them some days…") questioned necessity and purposively missed doses.
A subset described intentional nonadherence as a means of regaining control over their life and illness. In these narratives, loss of personal control was described. As one 51 year old Black male Concerns about physical and mental wellbeing resulted in unintentional nonadherence for some.
Sleeping too much and feeling fatigued resulted in missed doses ("I slept too long and missed the time for my pills"). Being depressed resulted in missed doses because of feeling unable to execute the behavior. One 74 year old White woman described that she always takes her medication with food so when she does not "feel strong enough to cook", she may wait to take her medication "until I feel better". 
Contextual Issues

Patterns of Medication Nonadherence
Four patterns of nonadherence emerged that help explain the complexity of medication adherence and provide important implications for intervention. Guided by the CSM, these four patterns elucidate the relative contribution of illness perceptions, beliefs, concerns, and contextual issues on the outcome of medication nonadherence.
Rarely Nonadherent
Twenty-five (22%) individuals described being adherent most of the time and missing medication only on rare occasions. These participants had no pattern of recurrent nonadherence or intentionally skipping medications. Their representation of HF was as an illness that was "lifethreatening" but controllable with medication. Most of these reported adequate access to healthcare services and providers who had educated them about their medicines, including how to manage a missed dose. As a result, they had structured routines in place to consistently adhere to even complex regimens and systems for managing missed doses when they occurred. They described routines and cues to help them remember medicines and had positive attitudes about the importance of their medicines.
Frequently Nonadherent
The second pattern was frequent nonadherence, but this nonadherence was unintentional. These participants (n=57, 51%) reported recurrent or routine nonadherence or patterns of nonadherence that could be linked to a situation or event (e.g., running out of medication). These situations caused them to forget on a regular basis. Although they described HF as a serious threat and noted the importance of medication, they routinely forgot to take doses and did not have effective cues or supports in place to facilitate adherence. Nor did they know how to manage missed doses. They described complicated regimens and other chronic conditions that made coping difficult. Importantly, they realized that their nonadherence was having negative health effects. They wanted to be better at taking medicines but did not have adequate knowledge or effective support in place to help them do so.
Intentionally Nonadherent
Twenty-one (19%) individuals described that they were intentionally nonadherent on a regular basis. They described purposively skipping medication and were likely to continue to do so.
They perceived HF as either low threat or they had negative attitudes about medication necessity.
They described a dislike of medication taking, medication side effects, or past negative experiences with side effects that influenced their behavior. Interestingly, medication adherence was described as an act of personal choice, and for some, a means of regaining personal control.
Nonadherence was situational and varied based on the day's events (work, vacation) and personal preferences (e.g., "If I just don't feel like taking <pill> today...I don't"). Further, they appraised their action of nonadherence as successful. One woman described that her husband, a
year old White patient with HF, "has this idea that he does not need to take his medicine every day". The husband explained, "…when I skip them…I don't feel differently…so I don't think I need them". Reformed Nonadherent
Nine individuals (8%) reported past nonadherence that was intentional and driven by negative attitudes and an attribution of low perceived threat of HF. However, a negative experience ("I was near death") reframed their HF illness perceptions and reinforced the importance of medication. In these cases, intentional nonadherence was appraised as unsuccessful, which prompted a change in action. Through education and communication by healthcare providers ("…<doctor> said straighten up…you are going to die from this….") and the adoption of strategies to reinforce adherence, they described a new commitment to taking medication "as I am supposed to do not whether I want to or not". Ongoing appraisal of success reinforced the importance of medication adherence. As a 57 year old Hispanic woman described, "…that was
the scariest day because I decided that I had nothing wrong with me and I had stopped taking all of the medications….I ended up here and I was real bad… I learned that it's (sic HF) gonna be with me for a long time…I learned that I have to take my medication…so I do now and I haven't been back here since…no more scary days."
Discussion
Medication nonadherence is recognized as a common and important problem in HF but the reasons contributing to the behavior are inadequately understood. Previous investigators have described many of the intentional and unintentional factors contributing to nonadherence, but in this study qualitative data from a substantial sample of adults with chronic HF were used to explore the contribution of the Necessity-Concerns-Framework to our understanding of these factors. Ninety percent of the sample reported being nonadherent at least intermittently. For many (60%), missing medication was unintentional and most commonly due to forgetfulness, but 27% reported intentional nonadherence. Four patterns of behavior were identified: 1) rarely nonadherent, 2) frequently nonadherent, 3) intentionally nonadherent, and 4) reformed nonadherent. Misperceptions about HF, beliefs, concerns, and contextual factors contributed to both intentional and unintentional medication nonadherence in these HF patients.
Others have also found that forgetting is the major reason for nonadherence in HF patients.
Aggarwal et al reported that 60% of patients reported sometimes forgetting to take their medications. 28 This finding suggests that interventions that augment prospective memory may decrease unintentional nonadherence. Prospective memory refers to the capacity to form, maintain, and execute an intention to perform a behavior at a particular point in the future. 29 Intention (e.g., the intention to take a medication) initiates a process of monitoring for cues (e.g., a pill bottle), detecting cues, recalling the intention and then executing the behavior. That is, in patients who intend to take a medication, the conscious recollection of the planned event will stimulate pill taking. However, deficits in prospective memory are unlikely to factor into nonadherence if the patient has no intention of taking the pill (intentional nonadherence). This distinction illustrates the importance of understanding the reasons underlying medication nonadherence.
Knowledge, attitudes and beliefs influence illness perceptions and adherence. An important knowledge deficit in these patients was failure to recognize fatigue as a symptom of HF, so this symptom did not motivate medication adherence. This finding is similar to that of Horowitz et al 30 who found that patients who misattributed their symptoms to aging were ineffective in managing their HF. These results suggest that the symptom of fatigue is vague to patients and warrants concerted attention during HF education sessions. Another knowledge deficit was in what to do if a medication dose is forgotten. Our finding that HF patients are uncertain about how to handle this situation is consistent with those of others who found that worrying and uncertainty were common in adults with diabetes experiencing insulin dosing problems. 31 Handling a missed dose is clearly a situational skill that needs to be emphasized in teaching
sessions.
An important belief with a powerful influence on adherence was the misconception that HF is not a threatening illness; individuals with this belief were likely to be intermittently nonadherent, at least until a hospitalization occurred. If 90% of patients admitted to some amount of nonadherence, a number consistent with early research in this area, 2 it seems safe to assume that any HF patient admitted to the hospital unexpectedly should be engaged in a discussion of medication adherence. After hospitalization, some intentionally nonadherent patients became "reformed" and attended carefully to medication adherence. This finding supports the theoretical framework, which proposes that changes in cognitions produce changes in coping attempts. 32 That is, as these patients became convinced that HF was life-threatening and medication could help, they became more adherent.
Concerns related to mood and regimen complexity interfered with adherence, as others have found. [33] [34] [35] The concern that may be less appreciated is loss of control. Although perceived control is known to predict adherence to diet and exercise, less is known about perceived control in relation to medication adherence. Quine and colleagues 36 identified perceived control as one of the leading predictors of medication nonadherence in a sample prescribed anti-hypertensive medications. In an earlier study, Piguet et al 37 found that persons with chronic pain who were prescribed antidepressants reported effects on cognition, emotions, and personality, which induced feelings of dependence and loss of control. A loss of control led to ambivalence about taking the antidepressants and contributed to nonadherence. Exploring these concerns with patients may reveal issues for further discussion.
Contextual issues such as provider and automatic pharmacy renewal mistakes contributed in important ways to nonadherence. Fragmented care, medication cost, and side-effects were all factors, a finding similar to that of Laba et al 38 who studied Australian adults prescribed medications for a diverse range of chronic conditions. They found that side effects and high cost were interpreted by patients as poor treatment decisions by providers, which contributed to nonadherence. Schuz and colleagues 39 suggested that if older people with multiple illnesses are convinced that their medication serves their specific needs, they are likely to be adherent. But if doctors prescribe too many medications, those with unacceptable side-effect profiles, or expensive medications, patients are more likely to be nonadherent. Providers may not realize that patients judge the quality of the care they receive at least partially based on the medications prescribed. Our results illustrate that failure to discuss cost, side-effects, and the reason for prescribing a medication, risk nonadherence that is potentially preventable.
This study was strengthened by the use of qualitative secondary analysis techniques and the relatively large sample size. However, several limitations need to be acknowledged. In each of the four original studies, similar general questions were used to gather accounts of self-care and fidelity to the interview guide was monitored. Three of the four studies were descriptive but one was an intervention study testing motivational interviewing. 40 In that study, these general questions were embedded within the intervention interview, but they were still the same questions. In a secondary data analysis such as this, the data rely on what was captured in the primary studies. Therefore, contradictory accounts of medication adherence that were not clarified at the time of the original interview required that discrepancies be resolved within the analysis process by determining the predominant theme in the transcribed data through content analysis. Another potential limitation is that we relied on subjective reports of medication adherence rather than objective measures. This led to subjective definitions of nonadherence.
That is, we were not able to quantify the number of missed doses so nonadherence was defined based on participant reports. took my medication" that should be provided routinely. Caregivers might be engaged to assist these patients to remember medications and should be provided with easy to understand information about the medications. In addition, role-playing exercises that facilitate problem solving and experiential learning may be useful. 42 Identification of concerns (e.g., perceived loss of control) may reveal other targets for intervention.
The intentionally nonadherent patients need the most attention. Assessment of the symptom pattern may reveal a reason for nonadherence. Interventions should address knowledge, beliefs, and attitudes influencing illness perceptions using a strategy like motivational interviewing or another approach that addresses behavioral intention. The reformed nonadherent patients might be engaged to talk with the intentionally nonadherent patients about their experiences, as the reformed patients were intentionally nonadherent in the past. Further research is needed to confirm the behavioral patterns and to test the efficacy of these suggested interventions.
In summary, 90% of the sample reported being at least intermittently nonadherent. Most nonadherence is unintentional and due to forgetfulness, but a significant proportion of HF patients are intentionally nonadherent. Four patterns of behavior were described with specific interventions suggested for each pattern. Misconceptions about HF, beliefs, concerns, and contextual factors contribute to both intentional and unintentional nonadherence. The implication for health care professionals is to suspect intermittent nonadherence and address misconceptions, beliefs, and concerns as one way to improve adherence in this population of patients.
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Figure Legend: The figure illustrates that illness perceptions influence patients' perceived need for a medication. If a drug is thought to be needed, medication adherence is likely. Individual beliefs and concerns greatly influence adherence. Even if the individual intends to adhere to the medication regimen, contextual factors such as finances may interfere with medication adherence.
Adapted from Horne 6 with permission. Table 2 . Detailed description of the steps used in analysis
Steps in Analysis Example
Sorting the primary data  Reviewed the qualitative data files and analysis files in Atlas.ti (e.g., memos, code books, etc.)
 Identified data to exclude (i.e., no mention of medication)
Identify codes and themes 
